1201902-17-1 Usage
Uses
Used in Medicinal Chemistry:
[6-(2-methyl-1H-imidazol-1-yl)-2-(4-methoxyphenyl)]quinoline is used as a compound in medicinal chemistry for its potential biological activity. The presence of the imidazole group suggests that it may play a role in various biological processes, making it a promising candidate for drug development.
Used in Drug Development:
In the field of drug development, [6-(2-methyl-1H-imidazol-1-yl)-2-(4-methoxyphenyl)]quinoline is used as a starting point for the design and synthesis of new drugs. [6-(2-methyl-1H-imidazol-1-yl)-2-(4-methoxyphenyl)]quinoline's unique structure, including the quinoline core and the substituted imidazole and methoxyphenyl groups, may offer specific advantages in targeting and interacting with biological systems.
Used in Pharmaceutical Research:
[6-(2-methyl-1H-imidazol-1-yl)-2-(4-methoxyphenyl)]quinoline is used as a research tool in pharmaceutical research to study its interactions with biological targets and to explore its potential therapeutic applications. [6-(2-methyl-1H-imidazol-1-yl)-2-(4-methoxyphenyl)]quinoline's structure and properties may provide valuable insights into the development of new drugs and therapies.
Used in Chemical Synthesis:
In the chemical synthesis industry, [6-(2-methyl-1H-imidazol-1-yl)-2-(4-methoxyphenyl)]quinoline may be used as a building block or intermediate in the synthesis of more complex molecules with specific applications in various fields, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 1201902-17-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,9,0 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1201902-17:
(9*1)+(8*2)+(7*0)+(6*1)+(5*9)+(4*0)+(3*2)+(2*1)+(1*7)=91
91 % 10 = 1
So 1201902-17-1 is a valid CAS Registry Number.
1201902-17-1Relevant academic research and scientific papers
6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS
-
, (2010/01/12)
The present invention is directed to 6-(1H-imidazo-1-yl)-2-aryl and 2-heteroaryl quinazoline and quinolines derivatives, compounds of formula (I), their pharmaceutical acceptable salts and solvates and corresponding pharmaceutical compositions, that acts
